Currently, Wave Life Sciences Ltd [WVE] is trading at $21.31, up 15.06%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WVE shares have gain 204.86% over the last week, with a monthly amount glided 171.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on December 09, 2025, when RBC Capital Mkts upgraded its rating to an Outperform but kept the price target unchanged to $27 for it. Previously, Wells Fargo started tracking the stock with Overweight rating on October 20, 2025, and set its price target to $18. On August 04, 2025, Canaccord Genuity initiated with a Buy rating and assigned a price target of $19 on the stock. Oppenheimer started tracking the stock assigning an Outperform rating and suggested a price target of $24 on July 28, 2025. Citigroup initiated its recommendation with a Buy and recommended $16 as its price target on July 16, 2025. In a note dated April 29, 2025, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $10 on this stock.
This stock has fluctuated between a low of $5.28 and a high of $19.60 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $29.22 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $21.31 at the most recent close of the market. An investor can expect a potential return of 37.12% based on the average WVE price forecast.
Analyzing the WVE fundamentals
Trailing Twelve Months sales for Wave Life Sciences Ltd [NASDAQ:WVE] were 109.23M which represents 199.11% growth. Gross Profit Margin for this corporation currently stands at 0.89% with Operating Profit Margin at -1.24%, Pretax Profit Margin comes in at -1.12%, and Net Profit Margin reading is -1.12%. To continue investigating profitability, this company’s Return on Assets is posted at -4.71, Equity is -0.73 and Total Capital is 2.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.90 points at the first support level, and at 16.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.73, and for the 2nd resistance point, it is at 24.14.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Wave Life Sciences Ltd [NASDAQ:WVE] is 2.51. Also, the Quick Ratio is 2.51, while the Cash Ratio stands at 2.28. Considering the valuation of this stock, the price to sales ratio is 32.62, the price to book ratio is 27.42.
Transactions by insiders
Recent insider trading involved KYLE MORAN, Officer, that happened on Dec 09 ’25 when 86000.0 shares were purchased. Affiliate, Henry Family Trust completed a deal on Dec 08 ’25 to buy 93445.0 shares. Meanwhile, Director HEIDI L WAGNER bought 14000.0 shares on Dec 08 ’25.
